Show simple item record

dc.contributor.authorLong, R
dc.contributor.authorConnolly, S
dc.contributor.authorSweeney, P
dc.date.accessioned2011-02-21T09:33:31Z
dc.date.available2011-02-21T09:33:31Z
dc.date.issued2010-10
dc.identifier.citationImpact of pharmacotherapy on the incidence of transurethral prostatectomy for benign prostatic hyperplasia and the implications for surgical training. 2010, 103 (9):281-2 Ir Med Jen
dc.identifier.issn0332-3102
dc.identifier.pmid21186754
dc.identifier.urihttp://hdl.handle.net/10147/122508
dc.description.abstractMedical therapy has become first line treatment for Benign Prostatic Hypertrophy (BPH) and in many cases TURP may no longer be required. Proof and quantification of this evolution in practice has been somewhat elusive and provided the principle impetus for this study. This is a retrospective study of BPH management in Republic of Ireland from 1995 to 2008. National treatment databases were sourced for numbers undergoing TURP and pharmacotherapy prescribing data was obtained from individual pharmaceutical companies. A total of 28,240 TURP's were performed nationally between 1995 and 2008. TURP's performed annually, decreased by 1,494 (51%), alpha-blocker prescriptions increased from 8,710 to 302,159 units and the number of urology trainees increased by 10 (60%). Clear association between decreases in TURP's and increases in pharmacotherapy for BPH is demonstrated. Implications on training likely exist and will require proper evaluation in order to maintain future standards in this surgical practice.
dc.language.isoenen
dc.subject.mesh5-alpha Reductase Inhibitors
dc.subject.meshAdrenergic alpha-1 Receptor Antagonists
dc.subject.meshDrug Utilization
dc.subject.meshHumans
dc.subject.meshIreland
dc.subject.meshMale
dc.subject.meshProstatic Hyperplasia
dc.subject.meshRetrospective Studies
dc.subject.meshTransurethral Resection of Prostate
dc.titleImpact of pharmacotherapy on the incidence of transurethral prostatectomy for benign prostatic hyperplasia and the implications for surgical training.en
dc.contributor.departmentMercy University Hospital, Grenville Place, Cork. ronanlong@hotmail.comen
dc.identifier.journalIrish medical journalen
refterms.dateFOA2018-08-22T11:13:11Z
html.description.abstractMedical therapy has become first line treatment for Benign Prostatic Hypertrophy (BPH) and in many cases TURP may no longer be required. Proof and quantification of this evolution in practice has been somewhat elusive and provided the principle impetus for this study. This is a retrospective study of BPH management in Republic of Ireland from 1995 to 2008. National treatment databases were sourced for numbers undergoing TURP and pharmacotherapy prescribing data was obtained from individual pharmaceutical companies. A total of 28,240 TURP's were performed nationally between 1995 and 2008. TURP's performed annually, decreased by 1,494 (51%), alpha-blocker prescriptions increased from 8,710 to 302,159 units and the number of urology trainees increased by 10 (60%). Clear association between decreases in TURP's and increases in pharmacotherapy for BPH is demonstrated. Implications on training likely exist and will require proper evaluation in order to maintain future standards in this surgical practice.


Files in this item

Thumbnail
Name:
Article5643.pdf
Size:
8.997Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record